Chris Rhodes
About
In The Last Decade
Chris Rhodes
41 papers receiving 439 citations
Peers
Comparison fields: 5 of 141
- Pharmaceutical Science 139
- Analytical Chemistry 74
- Molecular Biology 70
- Food Science 63
- Biomedical Engineering 58
Countries citing papers authored by Chris Rhodes
This map shows the geographic impact of Chris Rhodes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Rhodes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Rhodes more than expected).
Fields of papers citing papers by Chris Rhodes
This network shows the impact of papers produced by Chris Rhodes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Rhodes. The network helps show where Chris Rhodes may publish in the future.
Co-authorship network of co-authors of Chris Rhodes
This figure shows the co-authorship network connecting the top 25 collaborators of Chris Rhodes. A scholar is included among the top collaborators of Chris Rhodes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Rhodes. Chris Rhodes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | Retail sector in the UK | 2 |
| 4 | End of Brexit transition: chemicals regulation (REACH) | 1 |
| 5 | Motor industry: statistics and policy | 1 |
| 6 | Small businesses and the UK economy | 20 |
| 7 | 6 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 4 | |
| 11 | 76 | |
| 12 | 8 | |
| 13 | 4 | |
| 14 | 7 | |
| 15 | 4 | |
| 16 | 10 | |
| 17 | 5 | |
| 18 | 11 | |
| 19 | Automated analysis of drugs, and other substances of pharmaceutical interest | 0 |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.